PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...
- EDO platform observed to drive 25-fold higher level of oligonucleotide delivery to myotube nuclei compared to “naked” oligonucleotide - - EDO technology enabled delivery of therapeutic ...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...
5 mg/kg and 10 mg/kg data from phase 1 FREEDOM-DM1 study, using PGN-EDODM1 for the treatment of patients with Myotonic Dystrophy Type 1, expected by end of Q1 of 2025. 15 mg/kg data from phase 1 ...
PepGen Inc. (($PEPG)) announced an update on their ongoing clinical study. Study Overview: PepGen Inc. is conducting a Phase 2 clinical study ...
TEMPO.CO, Jakarta - The State-Owned Enterprises Ministry is finalizing a plan to establish a holding company in the oil and gas sector. Later, state gas company PGN will act as a sub-holding entity ...
TEMPO.CO, Jakarta-Former Energy and Mineral Resources Minister Arcandra Tahar has officially been named as president commissioner of the state-owned gas firm, PT Perusahaan Gas Negara (PGN). His ...
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed! tate-owned gas distributor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback